313 related articles for article (PubMed ID: 18038274)
1. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity of human non-small cell lung cancer xenografts to cyclophosphamide and cisplatin.
Mattern J; Wayss K; Volm M
In Vivo; 1987; 1(1):23-6. PubMed ID: 2856516
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic study of trimetrexate in combination with cisplatin.
Hudes GR; LaCreta F; Walczak J; Tinsley P; Litwin S; Comis RL; O'Dwyer PJ
Cancer Res; 1991 Jun; 51(12):3080-7. PubMed ID: 1828188
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent effectiveness of ADM and multiple cycles of DDP on a murine reticulum sarcoma.
Leonetti C; Zupi G; Calabresi F; Greco C
Anticancer Res; 1990; 10(1):45-8. PubMed ID: 2185688
[TBL] [Abstract][Full Text] [Related]
5. Kinetics and mechanism of the 1-beta-D-arabinofuranosylcytosine-induced potentiation of cis-diamminedichloroplatinum(II) cytotoxicity.
Vadi H; Drewinko B
Cancer Res; 1986 Mar; 46(3):1105-9. PubMed ID: 3080232
[TBL] [Abstract][Full Text] [Related]
6. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
[TBL] [Abstract][Full Text] [Related]
7. [Experimental chemotherapy of human gastric cancer cell lines in vitro and in nude mice].
Pan XY; Li FQ; Yu RJ; Xie GF; Wang H; Zhao LY; Zhang Q
Zhonghua Zhong Liu Za Zhi; 1988 Jan; 10(1):15-8. PubMed ID: 2843330
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
Bergerat JP; Green C; Drewinko B
Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of cisplatin antitumour activity by Ethyldeshydroxy-Sparsomycin in L1210 leukemia.
Hofs HP; Wagener DJ; De Valk-Bakker V; Van Rennes H; Van Zeist AJ; Van Den Broek LA; Ottenheijm HC
Anticancer Res; 1992; 12(1):167-70. PubMed ID: 1567164
[TBL] [Abstract][Full Text] [Related]
10. [Combined effects of cis-DDP and OK-432 on ascitic mastocytoma in mice: optimal period for the administration of OK-432].
Komatsu K; Nakamura W
C R Seances Soc Biol Fil; 1986; 180(1):117-20. PubMed ID: 2943364
[TBL] [Abstract][Full Text] [Related]
11. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
12. Antitumour effect of interferons, cytostatic drugs and their combinations in subrenal capsule assay (SRCA).
Kangas L; Cantell K; Grönroos M; Mäenpää J; Perilä M
Ann Chir Gynaecol Suppl; 1985; 199():60-3. PubMed ID: 2415035
[TBL] [Abstract][Full Text] [Related]
13. [Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
Fischel JL; Formento P; Berlion M; Berille J; Gioanni J; Bizzari JP; Milano G
Bull Cancer; 1992; 79(1):81-90. PubMed ID: 1520955
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
Wadler S; Schwartz EL
Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
[TBL] [Abstract][Full Text] [Related]
15. [Combined effect of CDDP with various types of antitumor drugs against P 388 leukemia].
Uchida T; Nishikawa K; Shibasaki C; Okamoto K; Arakawa M; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2275-82. PubMed ID: 2735770
[TBL] [Abstract][Full Text] [Related]
16. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Iwakawa M; Tofilon PJ; Arundel C; Milas L
Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
[TBL] [Abstract][Full Text] [Related]
17. Sequence and schedule-dependent synergy of trimetrexate in combination with 5-fluorouracil in vitro and in mice.
Elliott WL; Howard CT; Dykes DJ; Leopold WR
Cancer Res; 1989 Oct; 49(20):5586-90. PubMed ID: 2477146
[TBL] [Abstract][Full Text] [Related]
18. In vitro chemosensitivity of human lung cancer cell lines.
Ruckdeschel JC; Carney DN; Oie HK; Russell EK; Gazdar AF
Cancer Treat Rep; 1987; 71(7-8):697-704. PubMed ID: 3038314
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
Berek JS; Schink JC; Knox RM
Obstet Gynecol; 1989 Oct; 74(4):663-6. PubMed ID: 2797645
[TBL] [Abstract][Full Text] [Related]
20. [In vitro chemosensitivity tests of human lung small cell carcinomas--with reference to combination cancer chemotherapy].
Inada T
Nihon Geka Gakkai Zasshi; 1988 Feb; 89(2):256-64. PubMed ID: 2834634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
